Collectively, these results establish a coherent model in which probiotics alleviate IBS symptoms by preventing IκBα degradation, thereby inhibiting NF-κB p65 activation and suppressing downstream inflammatory cascades [47]. This evidence concerns the gene NFKBIA and irritable bowel syndrome.